Domestic studies have confirmed that non-insulin-based indicators such as TyG and METS-IR are not only closely related to the occurrence of atrial fibrillation, but can also predict recurrence after ablation and adverse cardiovascular outcomes (23–29, 40, 42). The gene discussed is INS; the disease is atrial fibrillation.